{"altmetric_id": 94195018, "counts": {"readers": {"citeulike": "0", "mendeley": "192", "connotea": "0"}, "total": {"posts_count": 40}, "twitter": {"unique_users_count": 23, "posts_count": 27}, "news": {"unique_users_count": 13, "unique_users": ["pr_newswire", "ticker_tech", "benzinga", "finanzen_ch", "vb_profiles", "morning_star", "the_street", "profitquotes_com", "kpvi", "jotup", "the_morning_journal", "biospace", "the_news_herald"], "posts_count": 13}}, "citation": {"altmetric_jid": "medrxiv", "authors": ["Burbelo, Peter D.", "Riedo, Francis X.", "Morishima, Chihiro", "Rawlings, Stephen", "Smith, Davey", "Das, Sanchita", "Strich, Jeffrey R.", "Chertow, Daniel S.", "Davey, Richard T.", "Cohen, Jeffrey I."], "doi": "10.1101/2020.04.20.20071423", "first_seen_on": "2020-11-13T07:39:49+00:00", "issns": [], "last_mentioned_on": 1619738117, "links": ["https://medrxiv.org/cgi/content/short/2020.04.20.20071423v1", "https://www.medrxiv.org/content/10.1101/2020.04.20.20071423v1", "http://medrxiv.org/lookup/doi/10.1101/2020.04.20.20071423", "https://www.medrxiv.org/content/10.1101/2020.04.20.20071423v1?fbclid=IwAR03F_XFT1IKejA6ZLeftemprXTxCzu_A76u4oeVRClHFkvmqk7sBIW4InU", "https://c212.net/c/link/?t=0&l=en&o=2948449-1&h=4004356550&u=https://www.medrxiv.org/content/10.1101/2020.04.20.20071423v1&a=(Burbelo+et+al.,+2020)", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239070/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239070/#:~:text=Antibodies%20to%20the%20nucleocapsid%20protein,those%20against%20the%20nucleocapsid%20protein"], "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/04/24/2020.04.20.20071423.full.pdf", "pmid": "32511445", "publisher": "Cold Spring Harbor Laboratory", "title": "Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/7c78d27c-edab-3b3e-b3a2-364eb0e6f2ea/"}, "altmetric_score": {"score": 105.15, "score_history": {"1y": 96.35, "6m": 2.6, "3m": 2.6, "1m": 1.25, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 105.15}, "context_for_score": {"all": {"total_number_of_other_articles": 17651001, "mean": 9.4318021098069, "rank": 234485, "this_scored_higher_than_pct": 98, "this_scored_higher_than": 17417123, "rank_type": "exact", "sample_size": 17651001, "percentile": 98}, "similar_age_3m": {"total_number_of_other_articles": 382094, "mean": 16.471931022208, "rank": 9590, "this_scored_higher_than_pct": 97, "this_scored_higher_than": 372511, "rank_type": "exact", "sample_size": 382094, "percentile": 97}, "this_journal": {"total_number_of_other_articles": 19788, "mean": 54.904388417222, "rank": 1413, "this_scored_higher_than_pct": 92, "this_scored_higher_than": 18374, "rank_type": "exact", "sample_size": 19788, "percentile": 92}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 2133, "mean": 66.628066572902, "rank": 196, "this_scored_higher_than_pct": 90, "this_scored_higher_than": 1938, "rank_type": "exact", "sample_size": 2133, "percentile": 90}}}, "demographics": {"poster_types": {"member_of_the_public": 20, "researcher": 1, "practitioner": 1, "science_communicator": 1}, "users": {"twitter": {"cohorts": {"Members of the public": 20, "Scientists": 1, "Practitioners (doctors, other healthcare professionals)": 1, "Science communicators (journalists, bloggers, editors)": 1}}, "mendeley": {"by_status": {"Student  > Postgraduate": 4, "Professor > Associate Professor": 9, "Researcher": 33, "Student  > Master": 22, "Student  > Ph. D. Student": 16, "Professor": 6, "Student  > Bachelor": 24, "Student  > Doctoral Student": 9, "Lecturer": 4, "Other": 12, "Librarian": 6, "Lecturer > Senior Lecturer": 1, "Unspecified": 2}, "by_discipline": {"Materials Science": 1, "Medicine and Dentistry": 49, "Social Sciences": 4, "Psychology": 1, "Mathematics": 1, "Pharmacology, Toxicology and Pharmaceutical Science": 2, "Environmental Science": 1, "Unspecified": 3, "Chemical Engineering": 3, "Engineering": 7, "Chemistry": 5, "Neuroscience": 1, "Energy": 1, "Economics, Econometrics and Finance": 1, "Immunology and Microbiology": 13, "Computer Science": 2, "Agricultural and Biological Sciences": 10, "Nursing and Health Professions": 6, "Linguistics": 1, "Business, Management and Accounting": 1, "Biochemistry, Genetics and Molecular Biology": 26}}}, "geo": {"twitter": {"US": 7, "NZ": 1, "MD": 1, "IT": 1, "CN": 1, "FR": 1, "GB": 1}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "921400462838042624"}, "tweet_id": "1253634771114176512"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "1842081248"}, "tweet_id": "1253636003237003264"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "1265089662"}, "tweet_id": "1253636583082938369"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "91824729"}, "tweet_id": "1253636776335478785"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "2382138736"}, "tweet_id": "1253641392775147521"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "106203272"}, "tweet_id": "1253720194872213505"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "1244711417657376768"}, "tweet_id": "1253832441544015876"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1254029488171737089"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1254029529632382977"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1254030826645446657"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "480875170"}, "tweet_id": "1254754301483892739"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "948631383634792449"}, "tweet_id": "1255354836134113280"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "773705857586585600"}, "tweet_id": "1255433883228811264"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "2183520866"}, "tweet_id": "1255435101237805056"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "984976058444369920"}, "tweet_id": "1255460775872925697"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "984976058444369920"}, "tweet_id": "1255462322958712835"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "419256305"}, "tweet_id": "1255473963049902080"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "2359778089"}, "tweet_id": "1256097064884338688"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "720319081"}, "tweet_id": "1256097597363638274"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "167542916"}, "tweet_id": "1263226693910757377"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "167542916"}, "tweet_id": "1263226781974310918"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "1180344534355648512"}, "tweet_id": "1263338454638870535"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1269101349464989696"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "1247242543940734977"}, "tweet_id": "1366329161434939400"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "3028350844"}, "tweet_id": "1366466823894540290"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "1259984664770609152"}, "tweet_id": "1387907375399645185"}, {"license": "gnip", "citation_ids": [94195018], "author": {"tweeter_id": "2414645220"}, "tweet_id": "1387908373883064329"}], "news": [{"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43305934967&p=1pl&v=1&x=3RC_UUyCE2bxP8eRj0oH9A", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:35:00+00:00", "summary": "ACCEL ELISA\u00ae: A new innovation in microwell design CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based\u2026", "author": {"name": "PR Newswire", "url": "http://www.prnewswire.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/545/normal/Screen_Shot_2016-01-06_at_16.29.18.png?1452097789"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43305938980&p=1pl&v=1&x=s1R7s1n8ZF8UjZeQJKCnyg", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:36:56+00:00", "summary": "ACCEL ELISA\u00ae: A new innovation in microwell design CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based\u2026", "author": {"name": "Ticker Tech", "url": "http://www.tickertech.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/724/normal/Screen_Shot_2016-01-26_at_15.37.40.png?1453822700"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43305977513&p=1pl&v=1&x=XZTqluvWLYM2Bkz6QuPS9A", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:35:00+00:00", "summary": "CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based enzyme linked immunosorbent assay (ELISA) for the\u2026", "author": {"name": "Benzinga", "url": "http://www.benzinga.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/738/normal/Screen_Shot_2016-01-26_at_15.59.27.png?1453824001"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43305977527&p=1pl&v=1&x=CqnVJMpCRAUGY3uN7GwHIQ", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:35:00+00:00", "summary": "CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based enzyme linked immunosorbent assay (ELISA) for the\u2026", "author": {"name": "Finanzen.ch", "url": "https://www.finanzen.ch/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/573/normal/Capture26.PNG?1575886265"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43305986508&p=1pl&v=1&x=wY8PH-lQ4MfI3uvuvdKDxg", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:44:55+00:00", "summary": "ACCEL ELISA\u00ae: A new innovation in microwell design CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based\u2026", "author": {"name": "VB Profiles", "url": "https://www.vbprofiles.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/839/normal/58.JPG?1576557158"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43305989036&p=1pl&v=1&x=hrIfeBr93kdKqqQfdia2jQ", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:35:00+00:00", "summary": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit ACCEL ELISA\u00ae: A new innovation in microwell design PR Newswire CINCINNATI, Oct.", "author": {"name": "Morning Star", "url": "https://www.morningstar.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/912/normal/Screen_Shot_2018-09-17_at_18.20.59.png?1537204915"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43305995587&p=1pl&v=1&x=t5J9mKvIHG5jncAO9culBQ", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:35:00+00:00", "summary": "ACCEL ELISA\u00ae: A new innovation in microwell design CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based\u2026", "author": {"name": "The Street", "url": "http://www.thestreet.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/809/normal/Screen_Shot_2016-01-27_at_10.05.56.png?1453889412"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43306108942&p=1pl&v=1&x=QwppZoTVTiqeDsN_LIh43Q", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T20:08:47+00:00", "summary": "ACCEL ELISA\u00ae: A new innovation in microwell design CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based\u2026", "author": {"name": "ProfitQuotes.com", "url": "http://www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=201908201908021405PR_NEWS_USPR_____DC29726", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/276/normal/logo7E.jpg?1567155044"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43306140948&p=1pl&v=1&x=gNPF5ze-5r7GMO_n7wEm6Q", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:35:00+00:00", "summary": "CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based enzyme linked immunosorbent assay (ELISA) for the\u2026", "author": {"name": "KPVI", "url": "https://www.kpvi.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/663/normal/Capture_kvpi.PNG?1576132656"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43306168140&p=1pl&v=1&x=yKQJkxjBaVs-2KM-JSTOTw", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T20:16:54+00:00", "summary": "CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA COVID-19 kit, a serological microplate-based enzyme linked immunosorbent assay (ELISA) for the\u2026", "author": {"name": "Jotup", "url": "https://jotup.co/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/231/normal/jotup-logo.png?1567071493"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43306367107&p=1pl&v=1&x=A-jIGrDxKzjvyeUgg7e46g", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:35:00+00:00", "summary": "CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based enzyme linked immunosorbent assay (ELISA) for the\u2026", "author": {"name": "The Morning Journal", "url": "https://www.morningjournal.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/674/normal/Capture_the_morning.PNG?1576140321"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43306469083&p=1pl&v=1&x=W1WM5JfDEajInFiryhkRug", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T00:00:00+00:00", "summary": "CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based enzyme linked immunosorbent assay (ELISA) for the\u2026", "author": {"name": "Biospace", "url": "http://www.biospace.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/375/normal/biospace.png?1437140433"}}, {"title": "VEO Diagnostics Announces U.S. Launch Of ACCEL ELISA\u00ae COVID-19 Total Antibody Test Kit", "url": "http://ct.moreover.com/?a=43306630858&p=1pl&v=1&x=GjfKNdFaX1fyzXpAPC1uwg", "license": "public", "citation_ids": [94195018], "posted_on": "2020-10-13T19:35:00+00:00", "summary": "CINCINNATI, Oct. 13, 2020 /PRNewswire/ -- VEO Diagnostics announces the launch and sole distribution rights in the United States to the ACCEL ELISA \u00ae COVID-19 kit, a serological microplate-based enzyme linked immunosorbent assay (ELISA) for the\u2026", "author": {"name": "The News-Herald", "url": "https://www.news-herald.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/708/normal/28.JPG?1576212966"}}]}, "score": 105.15, "images": {"small": "https://badges.altmetric.com/?size=64&score=106&types=mmmttttt", "medium": "https://badges.altmetric.com/?size=100&score=106&types=mmmttttt", "large": "https://badges.altmetric.com/?size=180&score=106&types=mmmttttt"}}